Viewing Study NCT01341951


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2025-12-27 @ 8:10 AM
Study NCT ID: NCT01341951
Status: UNKNOWN
Last Update Posted: 2011-04-26
First Post: 2011-04-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
Organization:

Study Overview

Official Title: G-CSF in Acute Liver Failure and Alcoholic Hepatitis - A Pilot Study
Status: UNKNOWN
Status Verified Date: 2011-01
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: G-CSF
Brief Summary: Granulocyte colony stimulating factor in acute liver failure and alcoholic hepatitis
Detailed Description: In this study 4 groups have been taken. Two groups of cases including Alcoholic patients and acute liver failure which are given G-CSF therapy and two groups of controls given standard therapy. Primary end point is to see the mobilization of CD-34 hematopoietic cells and survival. Secondary end point is to see the clinical and biochemical improvement in liver functions.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: